13.09.2005 16:11:00

New Training Release -- Oncology Handbook; Training Guide Just Released by Total Learning Concepts

Total Learning Concepts (TLC), a Publicis HealthcareCommunications Group (PHCG) company, announced today that the newtraining guide - Oncology Handbook - has just been released. The newOncology Handbook is a user-friendly and comprehensive update of aTotal Learning Concepts bestseller. This training guide is designed toprepare biopharmaceutical sales professionals to participate in theoncology treatment decision-making dialogue --leveraging theirfundamental understanding of the disease and treatment to enter intomeaningful interactions with physicians.

"The treatment of cancer is growing increasingly sophisticated andnew developments in oncology have dramatically affected the landscapefrom just a few years ago," states Shelley Spencer, President and COOof Total Learning Concepts. "The need for highly-trained oncologysales professionals has never been greater. The new Oncology Handbookis designed to fill this need through our reality-based learningmethod."

The new Oncology Handbook covers key scientific and clinicaltopics in the field of oncology with a real-world approach that equipssales professionals to frame oncology treatment benefits in terms ofthe latest developments in evidence-based clinical research. Thisindustry-leading learning tool:

-- Captures the current understanding of cancer at the molecular level

-- Outlines the therapeutic index of treatment, including efficacy, resistance, toxicities, multimodality approaches and drug combinations

-- Shows how scientific theory, clinical data and experience combine to guide treatment decision-making

-- Explores the emergence of "economic value" as a treatment decision factor

-- Highlights the differences between various oncology practices, including hospital community and private practices

-- Elucidates the drug development process so learners can intelligently participate in discussions about evidence-based patient care decisions and optimal outcomes

The new Oncology Handbook incorporates Total Learning Concepts'reality-based training method, which is designed to deliver real-worldeducational tools that result in an immediate impact. The OncologyHandbook provides biopharmaceutical sales professionals with asophisticated understanding of the disease and treatment issues thattranslate into making persuasive presentations to physicians.

For more information about the Oncology Handbook or to order theHandbook, contact Carrie Plantamura at 617-937-2831 or Brian Addesa at617-937-2831.

About Total Learning Concepts

Total Learning Concepts, a leading provider of pharmaceutical andbiotech sales training, merges the expertise of their 20 year legacywith training that is timely, innovative and groundbreaking. TLC hasdeveloped customized training materials used to launch more than 90pharmaceutical products worldwide, many of which are industryblockbusters. TLC is committed to providing real-world training thatcan be practically applied for immediate results and outstandingimpact. For more information regarding Total Learning Conceptsofferings, contact Shelley Spencer, President and COO at 617-937-2833.The company's website is at www.tlconline.com.

About Publicis Healthcare Communications Group

Publicis Healthcare Communications Group (PHCG), a member ofPublicis Groupe S.A., is the largest healthcare communications groupin the world. Worldwide healthcare services include Advertising,Medical Education, Sales and Marketing, Medical and ScientificAffairs, and Healthcare Consulting. PHCG offers its clients astrategic partnership, a strong focus on ensuring value for theirmarketing spend, and exceptional performance on their assignments.Publicis Groupe (Euronext Paris: 13057, NYSE: PUB) is the world'sfourth largest communications group, and a world leader in mediacounsel and buying. Services are provided in 104 countries on fivecontinents.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Analysen zu Publicis S.A.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Publicis S.A. 99,94 0,00% Publicis S.A.

Indizes in diesem Artikel

EURONEXT 100 1 524,39 0,09%
EURO STOXX 533,89 0,33%